RBC Capital Maintains Sector Perform on ResMed, Raises Price Target to $232

Benzinga · 10/25 17:44
RBC Capital analyst Craig Wong-Pan maintains ResMed (NYSE:RMD) with a Sector Perform and raises the price target from $224 to $232.